Dose Escalation Study of TAK-117 (MLN1117) in Subjects With Advanced Cancer

Clinical trial NCT01449370 · COMPLETED

Trial details

NCT number: NCT01449370
Sponsor: Millennium Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Solid Tumors

Start date: 2011-10-01
Primary completion: 2015-07-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.